期刊
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
卷 24, 期 1, 页码 88-99出版社
AMER SOC NEPHROLOGY
DOI: 10.1681/ASN.2012050503
关键词
-
资金
- Fondation pour la Recherche Medicale
- Societe Francaise de Nephrologie
- French Ministere de l'Education Nationale, de la Recherche et de la Technologie
- Institut National de la Sante et de la Recherche Medicale (INSERM)
- Institut National des Sciences Appliquees de Lyon (INSA-Lyon)
The mechanisms underlying the insulin resistance that frequently accompanies CKD are poorly understood, but the retention of renally excreted compounds may play a role. One such compound is p-cresyl sulfate (PCS), a protein-bound uremic toxin that originates from tyrosine metabolism by intestinal microbes. Here, we sought to determine whether PCS contributes to CKD-associated insulin resistance. Administering PCS to mice with normal kidney function for 4 weeks triggered insulin resistance, loss of fat mass, and ectopic redistribution of lipid in muscle and liver, mimicking features associated with CKD. Mice treated with PCS exhibited altered insulin signaling in skeletal muscle through ERK1/2 activation. In addition, exposing C2C12 myotubes to concentrations of PCS observed in CKD caused insulin resistance through direct activation of ERK1/2. Subtotal nephrectomy led to insulin resistance and dyslipidemia in mice, and treatment with the prebiotic arabino-xylo-oligosaccharide, which reduced serum PCS by decreasing intestinal production of p-cresol, prevented these metabolic derangements. Taken together, these data suggest that PCS contributes to insulin resistance and that targeting PCS may be a therapeutic strategy in CKD. J Am Soc Nephrol 24: 88-99, 2013. doi: 10.1681/ASN.2012050503
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据